#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Reproductive health care in women with rheumatoid arthritis, psoriasis and psoriatic arthritis of childbearing age in routine clinical practice


Authors: M. Olejárová 1;  Ž. Macejová 2;  S. Gkalpakiotis 3;  L. Procházková 4;  Z. Tóth 5;  P. Prágr 6
Authors‘ workplace: Revmatologický ústav, Praha 1;  1. interná klinika LF Univerzity Pavla Jozefa Šafárika, Košice 2;  Dermatovenerologická klinika 3. LF UK a FNKV, Praha 3;  Revmatologická klinika FN u sv. Anny v Brně 4;  Faculty of Medicine of the Univ ersity of Debrecen 5;  PHARMICO, a. s., Brno 6
Published in: Čes. Revmatol., 29, 2021, No. 2, p. 97-106.
Category:

Questionnaire survey among rheumatologists and dermatologists in the Czech and Slovak Republics and in Hungary

Overview

A certain number of rheumatology and dermatology patients are women of childbearing age who are diagnosed with inflammatory rheumatic diseases and psoriasis. Subsequently they are treated with disease-modifying drugs (including biological ones) while the proportion of women treated with any of the biological drugs is increasing. These patients often consider becoming pregnant and starting or expanding their families.
Aim of the study: The aim of the presented questionnaire survey was to find out how rheumatologists and dermatologists in their female patients with rheumatoid arthritis, psoriasis and psoriatic arthritis cope with the needs for family planning, pregnancy and breastfeeding as  well as their possible maternal concerns. The main task was to map the needs for communication between patients and physicians, collaboration with other medical specialists and potential impact of reproductive journey’s issues on the therapeutic requirements in real clinical practice.
Methods: It was a questionnaire survey with 55 questions (given in English language) focusing on identifying the needs related to the reproductive health of fertile female patients living with rheumatoid arthritis, psoriasis and psoriatic arthritis. A total of 82 rheumatologists from the Czech Republic, Hungary and Slovakia and 38 dermatologists from the Czech Republic and Slovakia participated in this investigation.
Results: The ratio of the fertile female patients with moderate to severe rheumatoid arthritis, psoriasis and psoriatic arthritis, i.e. between 18 and 45 years of age, represents 10 to 30%. Approximately two thirds of respondents discuss family planning with their patients when making a diagnosis. In the care a higher number of rheumatologists collaborate with a wider range of other specialists compare to dermatologists who mostly consult only a gynecologist-obstetrician. Half of rheumatologists usually modify systemic treatment only 6 months before the patient would like to get pregnant while dermatologists act on average much earlier. Drugs of the first choice against flares during pregnancy are glucocorticoids for both specialties. Information on family planning was most often acquired by healthcare professionals from official guidelines and recommendations as well as from conferences and congresses. The physicians would welcome more congresses and interdisciplinary forums based on case reports as the most useful sources of information.
Conclusion: Timely initiation of discussion about family planning and ongoing dialogue with healthcare professionals are important for all women of childbearing age. The implications of medical treatment must be considered in all women with rheumatoid arthritis, psoriasis and psoriatic arthritis who are sexually active, even if they are not actively planning to start a family. The need for better and open communication, more holistic, multidisciplinary, collaborative and integrated care about these patients consistently emerged in the survey.

Keywords:

reproductive health – Psoriatic arthritis – Psoriasis – rheumatoid arthritis – inflammatory rheumatic diseases – women’s health of childbearing age – need for communication


Sources
  1. van Vollenhoven RF. Sex differences in rheumatoid arthritis: more than meets the eye. BMC Med 2009; 7: 12.
  2. Eder L, Chandran V, Gladman DD. Gender-related differences in patients with psoriatic Arthritis. Int J Clin Rheumatol 2012; 7(6): 641–649.
  3. Birru Talabi M, Clowse MEB, Schwarz EB, Callegari LS, Moreland L, Borrero S. Family Planning Counseling for Women With Rheumatic Diseases. Arthritis Care Res (Hoboken) 2018; 70(2): 169–174.
  4. Rheumatoid Arthritis and Pregnancy. https://www.arthritis.org/health-wellness/healthy-living/family-relationships/family--planning/rheumatoid-arthritis-and-pregnancy
  5. Nelson-Piercy C, Vlaev I, Harris K, Fischer-Betz R. What factors could influence physicians’ management of women of childbearing age with chronic inflammatory disease? A systematic review of behavioural determinants of clinical inertia. BMC Health Serv Res 2019; 19(1): 863.
  6. Krause ML, Makol A. Management of rheumatoid arthritis during pregnancy: challenges and solutions. Open Access Rheumatol 2016; 8: 23-36.
  7. Levine D, Gottlieb A. Evaluation and management of psoriasis: an internist’s guide. Med Clin North Am 2009; 93(6): 1291–1303.
  8. Kimball AB, Leonardi C, Stahle M, Gulliver W, Chevrier M, Fakharzadeh S, Goyal K, Calabro S, Langholff W, Menter A; PSOLAR Steering Committee. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR). Br J Dermatol 2014; 171(1): 137–147.
  9. Meeuwis KA, de Hullu JA, van de Nieuwenhof HP, Evers AW, Massuger LF, van de Kerkhof PC, van Rossum MM. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol 2011; 164(6): 1247–1255.
  10. Kerschbaumer A, Fenzl KH, Erlacher L, Aletaha D. An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets. Wien Klin Wochenschr 2016; 128(21–22): 791–795.
  11. Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol 2019; 5(3): 141–150.
  12. Götestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016; 75(5): 795–810.
Labels
Dermatology & STDs Paediatric rheumatology Rheumatology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#